Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash flows (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Cash flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Loss from continuing operations $ (942,461) $ (1,345,227)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities - continuing operations:    
Depreciation and amortization 513,310 51,818
Deferred tax benefit (10,241) (17,043)
Amortization of right-of-use asset (4,552) 45,693
Stock-based compensation expense 405,414 309,328
Litigation settlement reserve (908,564) 75,000
Reduction of merchant reserve 190,000 380,000
Changes in operating assets and liabilities, net of effects of discontinued operations:    
Accounts receivable 467,524 (73,344)
Prepaid expenses and other current assets (57,694) (27,341)
Incremental direct costs (2,890)
Accounts payable (235) (352,236)
Accrued expenses (48,773) (29,086)
Deferred revenue (173,273) 322,255
Net cash used in operating activities - continuing operations (569,545) (663,073)
Net cash provided by operating activities - discontinued operations (712) (318)
Net cash used in operating activities (570,257) (663,391)
Cash flows from investing activities:    
Costs incurred to develop technology (1,907)
Payments for investment deposits (60,000)
Purchases of property and equipment (5,322) (20,357)
Net cash used in investing activities - continuing operations (7,229) (80,357)
Net cash used in investing activities - discontinued operations
Net cash provided used in investing activities (7,229) (80,357)
Cash flows from financing activities:    
Proceeds from the sale of common stock 1,166,500
Stock buyback plan (386,538)
Net cash provided by financing activities - continuing operations (386,538) 1,166,500
Net cash provided by financing activities (386,538) 1,166,500
Effect of exchange rate fluctuations on cash and cash equivalents 712 (32,556)
Net increase (decrease) in cash and cash equivalents (963,311) 390,016
Cash, cash equivalents, beginning of period 3,402,697 2,117,569
Cash and cash equivalents, end of period 2,439,386 2,507,585
Supplemental disclosures of other cash flow information:    
Non-cash stock issuance 400,000 166,500
Cash paid for income taxes